AbCellera’s partner, Eli Lilly and Company, will supply the U.S. government with 300,000 doses of bamlanivimab for allocation to high-risk patients VANCOUVER, British Columbia, November 9, 2020 – AbCellera today… Read More
-U.S. Food & Drug Administration grants Priority Review for voclosporin and sets PDUFA date of January 22, 2021 – – Cash, cash equivalents and investments totaled approximately $421 million at… Read More
– NL-201 enhances activity of checkpoint inhibitors and tumor-targeting antibodies and increases immune cell stimulation – SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company… Read More
For example, a BC college project is to find a practical method for calculating the total thermal resistance of a greenhouse. Algorithms are acquired to assess heat gain from sunlight… Read More
-Integrated analysis confirms addition of voclosporin to standard-of-care resulted in faster Renal Response compared to standard-of-care alone in lupus nephritis – – DDI study demonstrates no clinically meaningful interaction between… Read More
